Royal Bank of Canada’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6K Sell
1,307
-265
-17% -$1.11K ﹤0.01% 6388
2025
Q4
$7K Buy
1,572
+848
+117% +$3.23K ﹤0.01% 6612
2025
Q3
$4K Buy
724
+281
+63% +$1.27K ﹤0.01% 6776
2025
Q2
$2K Buy
+443
New +$1.75K ﹤0.01% 6836

Other funds holding SBC

Royal Bank of Canada's SBC Position: Q1 2026 in Review

Royal Bank of Canada reduced its SBC Medical Group (SBC) stake by 17% in Q1 2026, selling an estimated $1.11K and leaving 1,307 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #6388.

Royal Bank of Canada first reported a position in SBC in Q2 2025 and has held it in 4 quarters since. The position peaked at $7K in Q4 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • Royal Bank of Canada held 1,307 shares of SBC Medical Group worth $6K as of Q1 2026.
  • Royal Bank of Canada sold 265 SBC Medical Group shares in Q1 2026, an estimated $1.11K.
  • SBC Medical Group made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6388 holding.
  • Royal Bank of Canada first reported a position in SBC Medical Group in Q2 2025 and has held it in 4 quarters since.
  • Royal Bank of Canada's SBC Medical Group position peaked at $7K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.